Multimodal Analgesia Effect on Post Surgical Patient
Public ClinicalTrials.gov record NCT04240626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04240626
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- University of California, Davis
- Other
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Ativan Drug
- Dilaudid Injectable Product Drug
- Flexeril Oral Product Drug
- Hycet 7.5Mg-325Mg/15Ml Solution Drug
- Marcaine Injectable Product Drug
- Neurontin Drug
- Oxycodone Hydrochloride Drug
- Scopolamine patch Drug
- Tylenol Suspension Drug
- Zofran Injection Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 19, 2021
- Primary completion
- Jun 23, 2026
- Completion
- Jun 23, 2026
- Last update posted
- Aug 7, 2025
2021 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis Health | Sacramento | California | 95817 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04240626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04240626 live on ClinicalTrials.gov.